Chlamydial Genitourinary Infections Guidelines

1. CDC Grand Rounds: Chlamydia prevention: challenges and strategies for reducing disease burden and sequelae. MMWR Morb Mortal Wkly Rep. 2011 Apr 1. 60(12):370-3. [Medline].

2. [Guideline] Geisler WM. Diagnosis and management of uncomplicated Chlamydia trachomatis infections in adolescents and adults: summary of evidence reviewed for the 2010 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines. Clin Infect Dis. 2011 Dec. 53 Suppl 3:S92-8. [Medline].

3. [Guideline] Hammerschlag MR. Chlamydial and gonococcal infections in infants and children. Clin Infect Dis. 2011 Dec. 53 Suppl 3:S99-102. [Medline].

4. Keenan JD, Lakew T, Alemayehu W, Melese M, Porco TC, Yi E, et al. Clinical activity and polymerase chain reaction evidence of chlamydial infection after repeated mass antibiotic treatments for trachoma. Am J Trop Med Hyg. 2010 Mar. 82(3):482-7. [Medline]. [Full Text].

5. Centers for Disease Control and Prevention. Chlamydia screening among sexually active young female enrollees of health plans--United States, 2000-2007. MMWR Morb Mortal Wkly Rep. 2009 Apr 17. 58(14):362-5. [Medline]. [Full Text].

6. LeFevre ML, U.S. Preventive Services Task Force. Screening for Chlamydia and gonorrhea: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014 Dec 16. 161 (12):902-10. [Medline].

7. National Guideline Clearinghouse. Screening for chlamydial infection: recommendation statement. Available at http://guideline.gov/summary/summary.aspx?doc_id=10408. Accessed: March 23, 2009.

8. National Guideline Clearinghouse (NGC). Guideline synthesis: Screening, diagnosis management of chlamydial infection. National Guideline Clearinghouse (NGC) [Web site]. Rockville, MD: Agency for Healthcare Research and Quality (AHRQ); 2001 May (revised 2012 Feb). Available at https://www.guideline.gov/summaries/summary/48874/screening-for-chlamydia-and-gonorrhea-us-preventive-services-task-force-recommendation-statement?q=chlamydia. Accessed: September, 2014.

9. Srivastava P, Jha R, Bas S, Salhan S, Mittal A. In infertile women, cells from Chlamydia trachomatis infected sites release higher levels of interferon-gamma, interleukin-10 and tumor necrosis factor-alpha upon heat-shock-protein stimulation than fertile women. Reprod Biol Endocrinol. 2008 May 20. 6:20. [Medline]. [Full Text].

10. Ohman H, Tiitinen A, Halttunen M, Lehtinen M, Paavonen J, Surcel HM. Cytokine polymorphisms and severity of tubal damage in women with Chlamydia-associated infertility. J Infect Dis. 2009 May 1. 199(9):1353-9. [Medline].

11. Taylor BD, Darville T, Ferrell RE, Kammerer CM, Ness RB, Haggerty CL. Variants in toll-like receptor 1 and 4 genes are associated with Chlamydia trachomatis among women with pelvic inflammatory disease. J Infect Dis. 2012 Feb. 205(4):603-9. [Medline]. [Full Text].

12. Ahrens KR, Richardson LP, Courtney ME, McCarty C, Simoni J, Katon W. Laboratory-diagnosed sexually transmitted infections in former foster youth compared with peers. Pediatrics. 2010 Jul. 126(1):e97-e103. [Medline].

13. US Department of Health and Human Services. CDC. Sexually transmitted disease surveillance 2013. Atlanta. CDC. 2014;

14. Satterwhite CL, Torrone E, Meites E, Dunne EF, Mahajan R, Ocfemia MC, et al. Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008. Sex Transm Dis. 2013 Mar. 40(3):187-93. [Medline].

15. Torrone E, Papp J, Weinstock H. Prevalence of Chlamydia trachomatis genital infection among persons aged 14-39 years--United States, 2007-2012. MMWR Morb Mortal Wkly Rep. 2014 Sep 26. 63(38):834-8. [Medline].

16. WHO FACTSHEET. WHO. DEC 2015. [Full Text].

17. World Health Organization. Global incidence and prevalence of selected curable sexually transmitted infections—2008. World Health Organization. Available at http://apps.who.int/iris/bitstream/10665/75181/1/9789241503839_eng.pdf.

18. Guy RJ, Kong F, Goller J, Franklin N, Bergeri I, Dimech W, et al. A new national Chlamydia Sentinel Surveillance System in Australia: evaluation of the first stage of implementation. Commun Dis Intell. 2010 Sep. 34(3):319-28. [Medline].

19. Morgan J, Colonne C, Bell A. Trends of reported chlamydia infections and related complications in New Zealand, 1998-2008. Sex Health. 2011 Sep. 8(3):412-8. [Medline].

20. Goulet V, de Barbeyrac B, Raherison S, Prudhomme M, Semaille C, Warszawski J. Prevalence of Chlamydia trachomatis: results from the first national population-based survey in France. Sex Transm Infect. 2010 Aug. 86(4):263-70. [Medline].

21. Schmidt AJ, Marcus U. Self-reported history of sexually transmissible infections (STIs) and STI-related utilization of the German health care system by men who have sex with men: data from a large convenience sample. BMC Infect Dis. 2011 May 18. 11:132. [Medline]. [Full Text].

22. van Bergen JE, Fennema JS, van den Broek IV, Brouwers EE, de Feijter EM, Hoebe CJ, et al. Rationale, design, and results of the first screening round of a comprehensive, register-based, Chlamydia screening implementation programme in the Netherlands. BMC Infect Dis. 2010 Oct 7. 10:293. [Medline]. [Full Text].

23. World Health Organization. Chlamydia Trachomatis. Initiative for Vaccine Research. Available at http://www.who.int/vaccine_research/diseases/soa_std/en/index.html. Accessed: June 2009.

24. Centers for Disease Control and Prevention. Sexually transmitted diseases surveillance 2011. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. Available at http://www.cdc.gov/std/stats11/surv2011.pdf.

25. Bakken IJ. Chlamydia trachomatis and ectopic pregnancy: recent epidemiological findings. Curr Opin Infect Dis. 2008 Feb. 21(1):77-82. [Medline].

26. Scholes D, Stergachis A, Heidrich FE, Andrilla H, Holmes KK, Stamm WE. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med. 1996 May 23. 334 (21):1362-6. [Medline].

27. Kamwendo F, Forslin L, Bodin L, Danielsson D. Decreasing incidences of gonorrhea- and chlamydia-associated acute pelvic inflammatory disease. A 25-year study from an urban area of central Sweden. Sex Transm Dis. 1996 Sep-Oct. 23 (5):384-91. [Medline].

28. Quinn TC, Gaydos C, Shepherd M, Bobo L, Hook EW 3rd, Viscidi R, et al. Epidemiologic and microbiologic correlates of Chlamydia trachomatis infection in sexual partnerships. JAMA. 1996 Dec 4. 276(21):1737-42. [Medline].

29. Baud D, Goy G, Jaton K, Osterheld MC, Blumer S, Borel N, et al. Role of Chlamydia trachomatis in miscarriage. Emerg Infect Dis. 2011 Sep. 17(9):1630-5. [Medline]. [Full Text].

30. Rours GI, Duijts L, Moll HA, Arends LR, de Groot R, Jaddoe VW, et al. Chlamydia trachomatis infection during pregnancy associated with preterm delivery: a population-based prospective cohort study. Eur J Epidemiol. 2011 Jun. 26(6):493-502. [Medline]. [Full Text].

31. Peters RPH, Nijsten N, Mutsaers J, Jansen CL, Morré SA, van Leeuwen AP. Screening of Oropharynx and Anorectum Increases Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae Infection in Female STD Clinic Visitors. Sexually Transmitted Diseases. Sept 2011. 38(9):783-7.

32. Mangin D, Murdoch D, Wells JE, Coughlan E, Bagshaw S, Corwin P, et al. Chlamydia trachomatis testing sensitivity in midstream compared with first-void urine specimens. Ann Fam Med. 2012 Jan-Feb. 10(1):50-3. [Medline]. [Full Text].

33. [Guideline] Centers for Disease Control and Prevention. Chlamydial Infections. CDC. Available at http://www.cdc.gov/std/tg2015/chlamydia.htm. June 4, 2015;

34. Centers for Disease Control and Prevention. Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae--2014. MMWR Recomm Rep. 2014 Mar 14. 63 (RR-02):1-19. [Medline].

35. Knox J, Tabrizi SN, Miller P, Petoumenos K, Law M, Chen S, et al. Evaluation of self-collected samples in contrast to practitioner-collected samples for detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis by polymerase chain reaction among women living in remote areas. Sex Transm Dis. 2002 Nov. 29 (11):647-54. [Medline].

36. Masek BJ, Arora N, Quinn N, Aumakhan B, Holden J, Hardick A, et al. Performance of three nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae by use of self-collected vaginal swabs obtained via an Internet-based screening program. J Clin Microbiol. 2009 Jun. 47 (6):1663-7. [Medline].

37. Hislop J, Quayyum Z, Flett G, Boachie C, Fraser C, Mowatt G. Systematic review of the clinical effectiveness and cost-effectiveness of rapid point-of-care tests for the detection of genital chlamydia infection in women and men. Health Technol Assess. 2010 Jun. 14(29):1-97, iii-iv. [Medline].

38. Black CM, Driebe EM, Howard LA, Fajman NN, Sawyer MK, Girardet RG, et al. Multicenter study of nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in children being evaluated for sexual abuse. Pediatr Infect Dis J. 2009 Jul. 28(7):608-13. [Medline].

39. Gaydos CA, Van Der Pol B, Jett-Goheen M, Barnes M, Quinn N, Clark C, et al. Performance of the Cepheid CT/NG Xpert Rapid PCR Test for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J Clin Microbiol. 2013 Jun. 51(6):1666-72. [Medline]. [Full Text].

40. [Guideline] Workowski KA, Bolan GA, Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015 Jun 5. 64 (RR-03):1-137. [Medline].

41. Harkins AL, Munson E. Molecular Diagnosis of Sexually Transmitted Chlamydia trachomatis in the United States. ISRN Obstet Gynecol. 2011. 2011:279149. [Medline]. [Full Text].

42. Gaydos CA, Ferrero DV, Papp J. Laboratory aspects of screening men for Chlamydia trachomatis in the new millennium. Sex Transm Dis. 2008 Nov. 35(11 Suppl):S45-50. [Medline].

43. Chernesky M, Freund GG, Hook E 3rd, Leone P, D'Ascoli P, Martens M. Detection of Chlamydia trachomatis and Neisseria gonorrhoeae infections in North American women by testing SurePath liquid-based Pap specimens in APTIMA assays. J Clin Microbiol. 2007 Aug. 45(8):2434-8. [Medline]. [Full Text].

44. Centers for Disease Control and Prevention. Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae--2014. MMWR Recomm Rep. 2014 Mar 14. 63:1-19. [Medline]. [Full Text].

45. Hadgu A, Sternberg M. Reproducibility and specificity concerns associated with nucleic acid amplification tests for detecting Chlamydia trachomatis. Eur J Clin Microbiol Infect Dis. 2009 Jan. 28(1):9-15. [Medline].

46. Dukers-Muijrers NH, Morré SA, Speksnijder A, van der Sande MA, Hoebe CJ. Chlamydia trachomatis test-of-cure cannot be based on a single highly sensitive laboratory test taken at least 3 weeks after treatment. PLoS One. 2012. 7(3):e34108. [Medline]. [Full Text].

47. Kohlhoff SA, Hammerschlag MR. Treatment of Chlamydial infections: 2014 update. Expert Opin Pharmacother. 2015 Feb. 16 (2):205-12. [Medline].

48. Stamm WE, Batteiger BE, McCormack WM, Totten PA, Sternlicht A, Kivel NM. A randomized, double-blind study comparing single-dose rifalazil with single-dose azithromycin for the empirical treatment of nongonococcal urethritis in men. Sex Transm Dis. 2007 Aug. 34(8):545-52. [Medline].

49. Martin DH, Mroczkowski TF, Dalu ZA, McCarty J, Jones RB, Hopkins SJ, et al. A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. The Azithromycin for Chlamydial Infections Study Group. N Engl J Med. 1992 Sep 24. 327(13):921-5. [Medline].

50. Lau CY, Qureshi AK. Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomized clinical trials. Sex Transm Dis. 2002 Sep. 29 (9):497-502. [Medline].

51. Stamm WE, Hicks CB, Martin DH, Leone P, Hook EW 3rd, Cooper RH, et al. Azithromycin for empirical treatment of the nongonococcal urethritis syndrome in men. A randomized double-blind study. JAMA. 1995 Aug 16. 274(7):545-9. [Medline].

52. Geisler WM, Koltun WD, Abdelsayed N, Burigo J, Mena L, Taylor SN, et al. Safety and efficacy of WC2031 versus vibramycin for the treatment of uncomplicated urogenital Chlamydia trachomatis infection: a randomized, double-blind, double-dummy, active-controlled, multicenter trial. Clin Infect Dis. 2012 Jul. 55(1):82-8. [Medline].

53. CDC. Update to CDC’s Sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. Available at http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5614a3.htm?s_cid=mm5614a3_e.. Accessed: MMWR[serial online]. Apr 13 2007;56(14):332-336.

54. Phillips Campbell R, Kintner J, Whittimore J, Schoborg RV. Chlamydia muridarum enters a viable but non-infectious state in amoxicillin-treated BALB/c mice. Microbes Infect. 2012 Nov. 14 (13):1177-85. [Medline].

55. Wyrick PB. Chlamydia trachomatis persistence in vitro: an overview. J Infect Dis. 2010 Jun 15. 201 Suppl 2:S88-95. [Medline].

56. Magat AH, Alger LS, Nagey DA, Hatch V, Lovchik JC. Double-blind randomized study comparing amoxicillin and erythromycin for the treatment of Chlamydia trachomatis in pregnancy. Obstet Gynecol. 1993 May. 81(5 ( Pt 1)):745-9. [Medline].

57. Crombleholme WR, Schachter J, Grossman M, Landers DV, Sweet RL. Amoxicillin therapy for Chlamydia trachomatis in pregnancy. Obstet Gynecol. 1990 May. 75(5):752-6. [Medline].

58. Bowie WR, Yu JS, Jones HD. Partial efficacy of clindamycin against Chlamydia trachomatis in men with nongonococcal urethritis. Sex Transm Dis. 1986 Apr-Jun. 13(2):76-80. [Medline].

59. Alger LS, Lovchik JC. Comparative efficacy of clindamycin versus erythromycin in eradication of antenatal Chlamydia trachomatis. Am J Obstet Gynecol. 1991 Aug. 165(2):375-81. [Medline].

60. Campbell WF, Dodson MG. Clindamycin therapy for Chlamydia trachomatis in women. Am J Obstet Gynecol. 1990 Feb. 162(2):343-7. [Medline].

61. Barclay L. ACOG recommends expedited partner therapy for STIs. Medscape Medical News. WebMD Inc. Available at http://www.medscape.com/viewarticle/845221. May 22, 2015;

62. [Guideline] American College of Obstetricians and Gynecologists. Committee opinion no 632: expedited partner therapy in the management of gonorrhea and chlamydial infection. Obstet Gynecol. 2015 Jun. 125 (6):1526-8. [Medline].

63. [Guideline] World Health Organization. WHO Guidelines for the Treatment of Chlamydia trachomatis. World Health Organization. 2016. [Medline]. [Full Text].

64. Availability of cefixime 400 mg tablets--United States, April 2008. MMWR Morb Mortal Wkly Rep. 2008 Apr 25. 57(16):435. [Medline].

65. Bennett JE, Dolin R, Blaser MJ. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Elsevier Health Sciences. Kindle Edition.; Kindle Location 226428.

66. Centers for Disease Control and Prevention. Department of Health and Human Services. Sexually Transmitted Disease Surveillance, 2007. Available at http://www.cdc.gov/std/pubs. Accessed: December 2008.

67. Gaydos CA, Cartwright CP, Colaninno P, Welsch J, Holden J, Ho SY, et al. Performance of the Abbott RealTime CT/NG for detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J Clin Microbiol. 2010 Sep. 48(9):3236-43. [Medline]. [Full Text].

68. Hopkins MJ, Ashton LJ, Alloba F, Alawattegama A, Hart IJ. Validation of a laboratory-developed real-time PCR protocol for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine. Sex Transm Infect. 2010 Jun. 86(3):207-11. [Medline].

69. Johns Hopkins Antibiotic (ABX) Guide 2015.

70. National Guideline Clearinghouse. (1) Diseases characterized by urethritis and cervicitis. Sexually transmitted diseases treatment guidelines 2006. (2) Update to CDC’s sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. Available at http://guideline.gov/summary/summary.aspx?doc_id=10769. Accessed: March 23, 2009.

71. O'Connor CA, Shubkin CD. Adolescent STIs for primary care providers. Curr Opin Pediatr. 2012 Oct. 24(5):647-55. [Medline].

Shahab Qureshi, MD, FACP Attending Physician in General Internal Medicine, St Catharine's General Hospital; Associate Clinical Professor (Adjunct), McMaster University School of Medicine, Canada

Shahab Qureshi, MD, FACP is a member of the following medical societies: American College of Physicians, College of Physicians and Surgeons of Ontario, Ontario Medical Association

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Michael Stuart Bronze, MD David Ross Boyd Professor and Chairman, Department of Medicine, Stewart G Wolf Endowed Chair in Internal Medicine, Department of Medicine, University of Oklahoma Health Science Center; Master of the American College of Physicians; Fellow, Infectious Diseases Society of America

Michael Stuart Bronze, MD is a member of the following medical societies: Alpha Omega Alpha, American Medical Association, Oklahoma State Medical Association, Southern Society for Clinical Investigation, Association of Professors of Medicine, American College of Physicians, Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Jeffrey Blitstein, MD Staff Physician, Department of Internal Medicine, Division of Infectious Disease, VA New York Harbor Health Care System at Brooklyn

Disclosure: Nothing to disclose.

Marc James Grella, MD Clinical Instructor, Department of Pediatrics, Massachusetts General Hospital

Marc James Grella, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Pediatrics, American Medical Association, and Massachusetts Medical Society

Disclosure: Nothing to disclose.

Jonathan A Handler, MD HSG Chief Deployment Architect, Microsoft Corporation, Adjunct Associate Professor, Department of Emergency Medicine, Northwestern University, Feinberg School of Medine

Jonathan A Handler, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Renuka Heddurshetti, MD Fellow in Infectious Diseases, Department of Internal Medicine, State University of New York at Brooklyn

Renuka Heddurshetti, MD is a member of the following medical societies: American College of Physicians and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Debra E Houry, MD, MPH Director, Center for Injury Control, Associate Professor of Emergency Medicine, Department of Emergency Medicine, Emory University

Debra E Houry, MD, MPH is a member of the following medical societies: American College of Emergency Physicians, American Medical Association, American Public Health Association, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Rhett L Jackson, MD Associate Professor and Vice Chair for Education, Department of Medicine, Director, Internal Medicine Residency Program, University of Oklahoma College of Medicine; Assistant Chief, Medicine Service, Oklahoma City Veterans Affairs Hospital

Rhett L Jackson, MD is a member of the following medical societies: American College of Physicians-American Society of Internal Medicine and American Medical Association

Disclosure: Nothing to disclose.

Ashir Kumar, MD, MBBS, FAAP Professor Emeritus, Department of Pediatrics and Human Development, Michigan State University College of Human Medicine

Ashir Kumar, MD, MBBS, FAAP is a member of the following medical societies: American Association of Physicians of Indian Origin and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Richard Lavely, MD, JD, MS, MPH Lecturer in Health Policy and Administration, Department of Public Health, Yale University School of Medicine

Richard Lavely, MD, JD, MS, MPH is a member of the following medical societies: American College of Emergency Physicians, American College of Legal Medicine, and American Medical Association

Disclosure: Nothing to disclose.

John M Leedom, MD Professor Emeritus of Medicine, Keck School of Medicine of the University of Southern California

John M Leedom, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Physicians-American Society of Internal Medicine, American Society for Microbiology, Infectious Diseases Society of America, International AIDS Society, and Phi Beta Kappa

Disclosure: Nothing to disclose.

Larry I Lutwick, MD Professor of Medicine, State University of New York Downstate Medical School; Director, Infectious Diseases, Veterans Affairs New York Harbor Health Care System, Brooklyn Campus

Larry I Lutwick, MD is a member of the following medical societies: American College of Physicians and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Mark R Schleiss, MD American Legion Chair of Pediatrics, Professor of Pediatrics, Division Director, Division of Infectious Diseases and Immunology, Department of Pediatrics, University of Minnesota Medical School

Mark R Schleiss, MD is a member of the following medical societies: American Pediatric Society, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, and Society for Pediatric Research

Disclosure: Nothing to disclose.

Russell W Steele, MD Head, Division of Pediatric Infectious Diseases, Ochsner Children's Health Center; Clinical Professor, Department of Pediatrics, Tulane University School of Medicine

Russell W Steele, MD is a member of the following medical societies: American Academy of Pediatrics, American Association of Immunologists, American Pediatric Society, American Society for Microbiology, Infectious Diseases Society of America, Louisiana State Medical Society, Pediatric Infectious Diseases Society, Society for Pediatric Research, and Southern Medical Association

Disclosure: Nothing to disclose.

Kelley Struble, DO Fellow, Department of Infectious Diseases, University of Oklahoma College of Medicine

Kelley Struble, DO is a member of the following medical societies: American College of Physicians and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

What would you like to print?

• Print this section
• Print the entire contents of